Mobilization and collection of peripheral blood stem cells in healthy donors: Risks, adverse events and follow-up

Pathologie Biologie

Volumn 61, Issue 2, 2013, Pages 70-74

  Moalic, V ^a  

^a CHU MORVAN   (France)

Author keywords

Allogeneic stem cell transplantation; Follow up; Granulocyte colony stimulating factor; Healthy donors; Stem cell mobilization

Indexed keywords

CD34 ANTIGEN; PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANAPHYLACTIC SHOCK; ANTIINFLAMMATORY ACTIVITY; ARTERY THROMBOSIS; AUTOIMMUNE DISEASE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD DONOR; BLOOD SAMPLING; BONE PAIN; CANCER RISK; CAPILLARY LEAK SYNDROME; CHRONIC DRUG ADMINISTRATION; CHRONIC GRAFT VERSUS HOST DISEASE; DNA DAMAGE; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SURVEILLANCE PROGRAM; FATIGUE; FEVER; FOLLOW UP; GLOMERULONEPHRITIS; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INSOMNIA; LEUKAPHERESIS; LEUKEMIA; LUNG HEMORRHAGE; LYMPHOMA; MYELODYSPLASTIC SYNDROME; NAUSEA; NEOPLASM; NONHUMAN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVIEW; RHABDOMYOLYSIS; RISK FACTOR; SICKLE CELL CRISIS; SIDE EFFECT; SPLEEN RUPTURE; SPLENOMEGALY; STEM CELL MOBILIZATION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANIMALS; BLOOD DONORS; BLOOD SPECIMEN COLLECTION; FOLLOW-UP STUDIES; HEALTH; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RISK;

EID: 84876742187     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2012.10.003     Document Type: Review

References (50)

1. Michallet M. Allogeneic hematopoisetic stem cell transplantations. Trans Clin Biol 2011, 8:235-245.
2. Cashen A.F., Lazarus H.M., Devine S.M. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?. Bone Marrow Transplant 2007, 39:577-588.
3. Sourgens H., Lefrere F. A systematic review of available clinical evidence - filgrastim compared with lenograstim. Int J Clin Pharmacol Ther 2011, 49:510-518.
4. Lionne-Huyghe P., Kuhnowski F., Coiteux V., Bauters F., Morschhauser F. Indications of G-CSF administration in hematologic disorders. Bull Cancer 2006, 93:453-462.
5. Bay J.O., Peffault de Latour R., Tournilhac O., Choufi B., Chassagne J. Hematopoietic growth factors and autologous or allogeneic stem cell transplantation. Bull Cancer 2006, 93:473-482.
6. Liles W.C., Broxmeyer H.E., Rodger E., Wood B., Hubel K., Calandra G., et al. Mobilization of haematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003, 102:2728-2730.
7. Lemery S.J., Hsieh M.M., Smith A., Rao S., Khuu H.M., Theresa D., et al. A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of Plerixafor in healthy volunteers. Br J Haematol 2001, 153:66-75.
8. Neumann T., Kruger W.H., Busemann C., Kiefer T., Dolken G. Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone (letter). Bone Marrow Transplant 2011, 46:762-763.
9. Leotta S., Poidomani M., Mauro E., Spadaro A., Marturano E., Milone G. AMD3100 for urgent PBSC mobilization and allogeneic transplantation from a normal donor after failed marrow harvest (letter). Bone Marrow Transplant 2011, 46:314-316.
10. Ings S.J., Balsa C., Leverett D., Mackinnon S., Linch D.C., Watts M.J. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Haematol 2006, 134:517-525.
11. Geiger H., Szilvassy S.J., Ragland P., Van Zant G. Genetic analysis of progenitor cell mobilization by granulocyte colony-stimulating factor: verification and mechanisms for loci on murine chromosomes 2 and 11. Exp Hematol 2004, 32:60-67.
12. Suzuya H., Watanabe T., Nakagawa R., Watanabe H., Okamoto Y., Onishi T., et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang 2005, 89:229-235.
13. Lysak D., Koristek Z., Gasova Z., Skoumalova I., Jindra P. Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?. J Clin Apher 2011, 26:9-16.
14. Vasu S., Leitman S.F., Tisdale J.F., Hsieh M.M., Childs R.W., Barrett A.J., et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 2008, 112:2092-2100.
15. Martino M., Callea I., Condemi A., Dattola A., Irrera G., Marcuccio D., et al. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF). J Clin Apher 2006, 21:169-175.
16. Brissot E., Chevallier P., Guillaume T., Delaunay J., Ayari S., Dubruille V., et al. Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors (letter). Bone Marrow Transplant 2009, 44:613-615.
17. Anderlini P., Rizzo J.D., Nugent M.L., Schmitz N., Champlin R.E., Horowitz M.M. Peripheral blood stem cell donation: an analysis from the International bone marrow transplant registry (IBMTR) and European Group for blood and marrow transplant (EBMT) databases. Bone Marrow Transplant 2001, 27:689-692.
18. Tigue C.C., McKoy J.M., Evens A.M., Trifilio S.M., Tallman M.S., Bennett C.L. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the research on adverse drug events and reports project. Bone Marrow Transplant 2007, 40:185-192.
19. De la Rubia J., Arbona C., de Arriba F., del Cañizo C., Brunet S., Zamora C., et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 2002, 42:4-9.
20. D'Souza A., Jaiyesimi I., Trainor L., Venuturumili P. Granolocyte colony-stimulating factor administration: adverse events. Transf Med Rev 2008, 22:280-290.
21. Falzetti F., Aversa F., Minelli O., Tabilio A. Spontaneous rupture of spleen during peripheral blood stem cell mobilisation in a healthy donor. Lancet 1999, 353:555.
22. Dincer A.P., Gottschall J., Margolis D.A. Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization. Pediatr Hematol Oncol 2004, 26:761-763.
23. Becker P.S., Wagle M., Matous S., Swanson R., Pihan G., Lowry P., et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Bone Marrow Transplant 1997, 3:45-49.
24. Balaguer H., Galmes A., Ventayol G., Bargay J., Besalduch J. Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor. Transfusion 2004, 44:1260-1261.
25. Nuamah N.M., Goker H., Kilic Y.A., Dagmoura H., Cakmak A. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral blood stem cell following the administration of granulocyte colony-stimulating factor (G-CSF). A case report and review of the literature. Haematologica 2006, 91:9-11.
26. Stroncek D., Shawker T., Follmann D., Leitman S.F. G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 2003, 43:609-613.
27. Tulpule S., Shaw B.E., Makoni P., Little A.M., Madrigal J.A., Goldman J.M. Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor (letter). Bone Marrow Transplant 2009, 44:129-130.
28. Anderlini P., Körbling M., Dale D., Gratwohl A., Schmitz N., Stroncek D., et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood 1997, 90:903-908.
29. Topcuoglu P., Arat M., Dalva K., Ozcan M. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant 2004, 33:171-176.
30. Nasilowska-Adamska B., Perkowska-Ptasinska A., Tomaszewska A., Serwacka A., Marianska B. Acute glomerulonephritis in a donor as a side effect of allogeneic peripheral blood stem cell mobilization with granulocyte colony-stimulating factor. Int J Hematol 2010, 92:765-768.
31. Kopp H.G., Horger M., Faul C., Hartmann J.T., Kanz L., Lang P., et al. Granulocyte colony-stimulating factor-induced pulmonary hemorrhage in a healthy stem cell donor. J Clin Oncol 2007, 25:3174-3175.
32. Arimura K., Inoue H., Kukita T., Matsushita K., Akimot M., Kawamata N., et al. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica 2005, 90:27-29.
33. Schanz J., Wolf C., Koehler M., Maas J.H., Meyer M., Neumeyer H., et al. Rhabdomyolysis in allogeneic peripheral blood stem cell donors. Vox Sang 2004, 86:263-265.
34. Hacioglu S., Altuntas F., Kaynar L., Sari I., Patiroglu T., Cetin M. Rhabdomyolysis in a Healthy Peripheral Blood Stem Cell Donor following Mobilization with Filgrastim. Transfus Med Hemother 2009, 36:135-137.
35. De Azevedo A.M., Goldberg Tabak D. Life-threatening capillary leak syndrome after G-CSF mobilization and collection of peripheral blood progenitor cells for allogeneic transplantation. Bone Marrow Transplant 2001, 28(3):311-312.
36. Oiso N., Watanabe K., Kawada A. Granulocyte colony-stimulating factor-induced Sweet syndrome in a healthy donor. Br J Haematol 2006, 135:148.
37. Adler B.K., Salzman D.E., Carabasi M.H., Vaughan W.P., Reddy V.V., Prchal J.T. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood 2001, 97(15):3313-3314.
38. Kroschinsky F., Hundertmark J., Mauersberger S., Hermes M., Poppe-Thiede K., Rutt C., et al. Severe auto-immune hyperthyroidism after donation of growth factor-primed allogeneic peripheral blood progenitor cells. Haematologica 2004, 89:18-19.
39. Parkkali T., Volin L., Sirén M.K., Ruutu T. Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor. Bone Marrow Transplant 1996, 17:433-434.
40. Stroncek D.F., Clay M.E., Smith J., Ilstrup S., Oldham F., McCullough J. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion 1996, 36:596-600.
41. Halter J., Kodera Y., Ispizua A.U., Greinix H.T., Schmitz N., Favre G., et al. Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica 2009, 94:94-101.
42. Makita K., Ohta K., Mugitani A., Hagihara K., Ohta T., Yamane T., et al. Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest. Bone Marrow Transplant 2004, 33:661-665.
43. Bennett C.L., Evens A.M., Andritsos L.A., Balasubramanian L., Mai M., Fisher M.J., et al. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol 2006, 135:642-650.
44. Holig K., Kramer F., Kroschinsky F., Bornhauser M., Mengling T., Schmidt A., et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood 2009, 114:3757-3763.
45. Anderlini P., Champlin R.E. Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 2008, 111:1767-1772.
46. Minelli O., Falzetti F., Di Ianni M., Onorato M., Plebani S., Silvani C., et al. G-CSF-induced thrombocytopenia in a healthy donor (letter). Bone Marrow Transplant 2009, 43:263-264.
47. Hernández J.M., Castilla C., Gutiérrez N.C., Isidro I.M., Delgado M., de las Rivas J., et al. Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes. Leukemia 2005, 19:1088-1091.
48. Confer D.L., Miller J.P. Long-term safety of filgrastim administration (letter). Br J Haematol 2007, 137:77-78.
49. Hasenclever D., Sextro M. Safety of AlloPBPCT donors: biometrical considerations on monitoring long-term risks. Bone Marrow Transplant 1996, 17(Suppl. 2):S28-S30.
50. Rosenberg P.S., Alter B.P., Bolyard A.A., Bonilla M.A., Boxer L.A., Cham B., et al. Severe Chronic Neutropenia International Registry. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006, 107:4628-4635.